Energy Fuels Acquires RadTran LLC

Radon Medical Imaging Acquires Alpha Imaging

November 19, 2024

Healthcare Services

Radon Medical Imaging, a PE-backed independent service organization, acquired Alpha Imaging of Willoughby, Ohio in an add-on transaction closed in October 2024. The deal expands Radon's geographic footprint and service and distribution capabilities in medical imaging equipment across the eastern U.S.

5th Century Partners Acquires Radon Medical Imaging

December 2, 2022

Healthcare Services

5th Century Partners has acquired Radon Medical Imaging, a provider of medical imaging equipment service, sales, and distribution, with unitranche debt and a minority equity investment provided by Avante Capital Partners to support the transaction. The deal positions Radon as the platform for growth in medical imaging services and will leverage Avante’s flexible capital to support the company’s expansion.

Radiance Technologies Acquires Phased n Research

March 31, 2025

Aerospace & Defense

Radiance Technologies, a 100% employee‑owned prime contractor based in Huntsville, Alabama, has acquired Phased n Research, a radar and electronic warfare (EW) engineering firm founded in 2018. The deal brings Phasedn’s radar, modeling & simulation, and EW capabilities into Radiance’s portfolio; founder Dr. Bassem Mahafza will move to an emeritus/advisor role and Dr. Mark Tillman will become President of Phasedn to ensure continuity and alignment with Department of Defense modernization efforts.

Oklo Acquires Atomic Alchemy to Secure Domestic Radioisotope Supply

November 15, 2024

Energy

Oklo, the Sam Altman–backed small-reactor developer, is acquiring US radioisotope producer Atomic Alchemy in an all-stock transaction valued at $25 million. The deal will vertically integrate radioisotope and fuel production to secure domestic supplies for Oklo’s reactors and create a complementary revenue stream for medical and industrial isotopes.

Energy Fuels Acquires Base Resources

October 2, 2024

Energy

Energy Fuels Inc. completed the acquisition of Base Resources Limited in an all-share deal valued at approximately US$178.4 million, securing the Toliara Project in Madagascar and Base's heavy mineral sands capabilities. The acquisition provides Energy Fuels with additional monazite feedstock for rare earth element processing, potential titanium and zirconium production, and expands its critical minerals and supply-chain capabilities for clean-energy and defense markets.

AstraZeneca Acquires Fusion Pharmaceuticals

March 19, 2024

Biotechnology

AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage company developing next-generation actinium-based radioconjugates, for $21.00 per share in cash plus a non-transferable contingent value right that could bring the total to approximately $2.4 billion. The acquisition adds Fusion's pipeline (including FPI-2265 for mCRPC), R&D and manufacturing capabilities in radioconjugates and strengthens AstraZeneca's oncology portfolio and presence in Canada.